Does it Matter Whether Canada's Separate Health Technology Assessment Process for Cancer Drugs has an Economic Rationale?

Subjects

Subjects :

Antineoplastic Agents economics
Canada
Humans
Neoplasms economics
Antineoplastic Agents therapeutic use
Neoplasms drug therapy
Technology Assessment, Biomedical methods

Details

Language :

English

ISSN :

1179-2027

Volume :

33

Issue :

8

Database :

MEDLINE

Journal :

PharmacoEconomics

Publication Type :

Editorial & Opinion

Accession number :

25939500

Full Text :

https://doi.org/10.1007/s40273-015-0278-7